{"count":43797,"next":"https://cinder.proteo.info/api/ms_vocab/?format=json&limit=20&offset=23480&ordering=-name","previous":"https://cinder.proteo.info/api/ms_vocab/?format=json&limit=20&offset=23440&ordering=-name","results":[{"accession":"CLO:0019526","name":"GM16391 cell","definition":"[' TRICHOTHIODYSTROPHY; TTD ICHTHYOSIFORM ERYTHRODERMA WITH HAIR ABNORMALITY AND MENTAL AND GROWTH RETARDATION, INCLUDED']","term_type":"cell line"},{"accession":"CLO:0019389","name":"GM16390 cell","definition":"[' XERODERMA PIGMENTOSUM, COMPLEMENTATION GROUP D; XPD']","term_type":"cell line"},{"accession":"CLO:0019385","name":"GM16389 cell","definition":"[' POPLITEAL PTERYGIUM SYNDROME, LETHAL TYPE; BARTSOCAS-PAPAS SYNDROME; BPS']","term_type":"cell line"},{"accession":"CLO:0019394","name":"GM16387 cell","definition":"[' SOLUTE CARRIER FAMILY 3, MEMBER 1; SLC3A1 CYSTINURIA; CSNU']","term_type":"cell line"},{"accession":"CLO:0019392","name":"GM16386 cell","definition":"[' XERODERMA PIGMENTOSUM, COMPLEMENTATION GROUP C; XPC']","term_type":"cell line"},{"accession":"CLO:0019398","name":"GM16385 cell","definition":"[' XERODERMA PIGMENTOSUM, COMPLEMENTATION GROUP C; XPC']","term_type":"cell line"},{"accession":"CLO:0019396","name":"GM16384 cell","definition":"[' XERODERMA PIGMENTOSUM, COMPLEMENTATION GROUP C; XPC']","term_type":"cell line"},{"accession":"CLO:0019400","name":"GM16383 cell","definition":"[' XERODERMA PIGMENTOSUM, COMPLEMENTATION GROUP C; XPC']","term_type":"cell line"},{"accession":"CLO:0019399","name":"GM16382 cell","definition":"[' RETT SYNDROME; RTT METHYL-CPG-BINDING PROTEIN 2; MECP2']","term_type":"cell line"},{"accession":"CLO:0019404","name":"GM16381 cell","definition":"[' XERODERMA PIGMENTOSUM, COMPLEMENTATION GROUP C; XPC']","term_type":"cell line"},{"accession":"CLO:0019401","name":"GM16380 cell","definition":"[' XERODERMA PIGMENTOSUM, COMPLEMENTATION GROUP C; XPC']","term_type":"cell line"},{"accession":"CLO:0019415","name":"GM16379 cell","definition":"[' XERODERMA PIGMENTOSUM, COMPLEMENTATION GROUP C; XPC']","term_type":"cell line"},{"accession":"CLO:0019414","name":"GM16378 cell","definition":"[' PINEAL HYPERPLASIA, INSULIN-RESISTANT DIABETES MELLITUS, AND SOMATIC ABNORMALITIES; RABSON-MENDENHALL SYNDROME LEPRECHAUNISM']","term_type":"cell line"},{"accession":"CLO:0019411","name":"GM16377 cell","definition":"[' BLOOM SYNDROME; BLM RECQ PROTEIN-LIKE 3; RECQL3']","term_type":"cell line"},{"accession":"CLO:0019421","name":"GM16375 cell","definition":"[' RECQ PROTEIN-LIKE 3; RECQL3 BLOOM SYNDROME; BLM']","term_type":"cell line"},{"accession":"CLO:0019420","name":"GM16372 cell","definition":"[' HYPOPARATHYROIDISM-RETARDATION-DYSMORPHISM SYNDROME; HRD; SANJAD-SAKATI SYNDROME']","term_type":"cell line"},{"accession":"CLO:0019419","name":"GM16370 cell","definition":"[' XERODERMA PIGMENTOSUM, COMPLEMENTATION GROUP C; XPC']","term_type":"cell line"},{"accession":"CLO:0019418","name":"GM16368 cell","definition":"[' RETT SYNDROME; RTT METHYL-CPG-BINDING PROTEIN 2; MECP2']","term_type":"cell line"},{"accession":"CLO:0019425","name":"GM16352 cell","definition":"[' FACIOSCAPULOHUMERAL MUSCULAR DYSTROPHY; TYPE UNKNOWN  (FSHD)']","term_type":"cell line"},{"accession":"CLO:0019424","name":"GM16351 cell","definition":"[' FACIOSCAPULOHUMERAL MUSCULAR DYSTROPHY; TYPE UNKNOWN  (FSHD)']","term_type":"cell line"}]}